An anti-CD22-seco-CBI-Dimer ADC for the treatment of non-Hodgkin lymphoma that provides a longer duration of response than auristatin ADCs in preclinical models
| Image |  |
|---|---|
| Description | scientific article published on 03 December 2020 |
| Author/s |
author: Montserrat Carrasco-Triguero Douglas D Leipold Donna W Lee |
| Publication date | December 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |